VHOSPITAL.CLINIC · Drug Reference
Pitavastatin is a statin (HMG-CoA reductase inhibitor) that reduces LDL cholesterol and lowers the risk of cardiovascular events.
Statins inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis in the liver. By reducing LDL cholesterol, they substantially reduce cardiovascular risk.
First-line treatment for hypercholesterolaemia and primary/secondary prevention of cardiovascular disease including heart attack and stroke.
Muscle symptoms are the most common concern — report unexplained muscle pain, weakness, or tenderness. Liver function monitoring is recommended in some guidelines.
Atorvastatin
Atorvastatin is a statin (HMG-CoA reductase inhibitor) that reduces LDL cholesterol and lowers the risk of cardiovascular events.
Simvastatin
Simvastatin is a statin (HMG-CoA reductase inhibitor) that reduces LDL cholesterol and lowers the risk of cardiovascular events.
Rosuvastatin
Rosuvastatin is a statin (HMG-CoA reductase inhibitor) that reduces LDL cholesterol and lowers the risk of cardiovascular events.
Pravastatin
Pravastatin is a statin (HMG-CoA reductase inhibitor) that reduces LDL cholesterol and lowers the risk of cardiovascular events.
Describe your symptoms and concerns and get a structured clinical assessment — possible causes, red flags, and recommended next steps.
Start Free AI Analysis →Medical Disclaimer: This drug reference is provided for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or qualified health provider before starting, stopping, or changing any medication. Information reviewed by the vHospital Editorial Team · Sources: WHO, BNF, FDA prescribing information, UpToDate.